Literature DB >> 2543752

The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).

G Fox1, N R Parry, P V Barnett, B McGinn, D J Rowlands, F Brown.   

Abstract

The amino acid sequence RGD (arginine-glycine-aspartic acid) is highly conserved in the VP1 protein of foot-and-mouth disease virus (FMDV), despite being situated in the immunodominant hypervariable region between amino acids 135 and 160. RGD-containing proteins are known to be important in promoting cell attachment in several different systems, and we report here that synthetic peptides containing this sequence are able to inhibit attachment of the virus to baby hamster kidney (BHK) cells. Inhibition was dose-dependent and could be reversed on removal of the peptide. A synthetic peptide corresponding to a portion of the same hypervariable region but not containing the RGD sequence did not inhibit virus attachment under the same conditions. Antibody against the RGD region of VP1 blocked attachment of the virus to BHK cells, and neutralizing monoclonal antibodies, which neutralize virus by preventing cell attachment, were blocked by RGD-containing peptides from binding virus in an ELISA test. Cleavage of the C-terminal region of virus VP1 in situ with proteolytic enzymes reduced cell attachment, and antiserum against a peptide corresponding to this region was also able to inhibit attachment of virus to BHK cells. These results indicate that the amino acid sequence RGD at positions 145 to 147 and amino acids from the C-terminal region of VP1 (positions 203 to 213) contribute to the cell attachment site on FMDV for BHK cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543752     DOI: 10.1099/0022-1317-70-3-625

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  133 in total

1.  Genetical and immunological analysis of recent Asian type A and O foot-and-mouth disease virus isolates.

Authors:  B Freiberg; M M Rahman; O Marquardt
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Arginine-glycine-aspartic acid motif is critical for human parechovirus 1 entry.

Authors:  Y Boonyakiat; P J Hughes; F Ghazi; G Stanway
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Viral evolution toward change in receptor usage: adaptation of a major group human rhinovirus to grow in ICAM-1-negative cells.

Authors:  A Reischl; M Reithmayer; G Winsauer; R Moser; I Gösler; D Blaas
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Identification of specific cucumber necrosis virus coat protein amino acids affecting fungus transmission and zoospore attachment.

Authors:  K Kakani; J Y Sgro; D Rochon
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 5.  Picornavirus uncoating.

Authors:  M S Smyth; J H Martin
Journal:  Mol Pathol       Date:  2002-08

Review 6.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 7.  Insights into neutralization of animal viruses gained from study of influenza virus.

Authors:  M C Outlaw; N J Dimmock
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

8.  Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture.

Authors:  E Rieder; B Baxt; P W Mason
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group.

Authors:  G Stanway; N Kalkkinen; M Roivainen; F Ghazi; M Khan; M Smyth; O Meurman; T Hyypiä
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Capsid region involved in hepatitis A virus binding to glycophorin A of the erythrocyte membrane.

Authors:  Glòria Sánchez; Lluís Aragonès; M Isabel Costafreda; Enric Ribes; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.